Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
PM
I'd have more respect for your posts if you didn't call out Porky for "deramping". He's been proven correct about the fundraise and the SP. So, why don't you eat a little humble pie?
Perhaps tell us why you think a deal for CLX is due when another £400,000 was raised for further R&D?
Or why you think the lab is such a success that they need more money for "brand establishment"?
When was the last actual agreement with a University to develop a new compound (as per the "strategy")?
This Board are lifestyle junkies and a change is needed.
🤣
Are you selling up OB? Your original post indicates even you've had enough.
OB,
The BOD are not listening, nor do they appear to have any intention of doing so.
Dr Cox, in particular, seems very adept at avoiding any challenge to his grip on power. Treharne continually fails to deliver in his role as "Corporate Development Manager".
None of the legacy assets have produced income, or a deal, despite Dr Hargreaves analysis and belief in 201.
Where are the promised evaluations? Why don't other universities want to work with Valirx? Why can't we sell the "strategy"? Why do Cytolytix and the lab need more money? What is the SAB actually doing?
The one dissenting voice (Stella) has been pushed out and the Board have now closed ranks, conveniently, just a couple of weeks after the fundraise.
Without news we'll probably be sub 5p next week.
We've just changed broker, probably because the last one ran out of fundraising options.
Is it any wonder investors are baying for blood?
OB,
The BOD are not listening, nor do they appear to have any intention of doing so.
Dr Cox, in particular, seems very adept at avoiding any challenge to his grip on power. Treharne continually fails to deliver in his role as "Corporate Development Manager".
None of the legacy assets have produced income, or a deal, despite Dr Hargreaves analysis and belief in 201.
Where are the promised evaluations? Don't other universities want to work with Valirx? Why can't we sell the "strategy"?
The one dissenting voice (Stella) has been pushed out. The Board have now closed ranks, conveniently just a couple of weeks after the fundraise.
Is it any wonder investors are annoyed?
"Very high risk" - is that the best analysis you can provide?
It's a diamond/valuable mineral mining operation, in a remote jurisdiction, in SA.
Did you consider such mining occurs with a gentleman's agreement over a cup of tea?
Dennis seems confident the Army will get to grips with the Zama Zama.
Diamonds by the end of February, marvellous!!
Of more interest is the purchase/loan of a magnetic separator combined into a deal with potential offtake partners.
I believe an inflection point is close.
Agreed,
The one person with any commercial acumen has dumped Valirx, in all probability due to clashing with Cox and Dilly over the lack of progress.
Meanwhile the perennial underachievers remain in situ, with plenty of time to plan their next fundraise.
The AGM can't come quick enough.
Non-compliance deadline approaching and Reebok launch due.
Interesting...🤔
Fair enough Northern,
So what's your solution?
A complete Board clear out? If so, who will takeover that understands the detail of the pipeline, it's contacts and can progress the business.
Everyone suggests Professor Hargreaves but has he the appetite for it, given his other commitments?
It's cheap talk to criticise Suzy, but not many people seem to post an alternative.
For the record , my preference would be Stella as CEO, with Suzy reverting to CSO.
At the risk of turning this into a serious debate (!), I'm not sure Suzy is the problem, it's the freeloading inner circle that need culling.
Personally I really like Suzy's lab/evaluation strategy, which I believe will pay off. She's an accomplished scientist and a fantastic ambassador for women's health.
The problem is the arrogance of Cox towards shareholders and the failure of Treharne/Tralau-Stewart to deliver any monetary value.
If Stella and/or Professor Hargreaves get involved to clear out the deadwood, then we'd all have a renewed sense of optimism.
EUDA up to $1.55 (+5.44%)
The market seems to think the merger will happen.
Trouble is, with such a modest upfront payment for 201, it won't be a big SP rise. Plus, they'll be plenty of 10% flippers of placement shares to hold us back.
I think we're stuck at sub 10p for the foreseeable future, unless Cytolytix gets funded for P1 with an upfront payment.
However, Cox and Treharne haven't managed to sell a bean in three years, so I ain't hopeful.
Stella for me. 🍺
Form 8-k
Internal promotion and the IngenioSpec deal.
http://tinyurl.com/3bh3vbtj
"As compensation for his services, the Company shall pay Mr. Abondano a base salary of $140,000 per year. Mr. Abondano shall also have the right to receive a cash bonus of $30,000 at the end of any fiscal quarter in which the Company achieves $1,000,000 or more in E-commerce revenue"
That's an ambitious target!! 😁
Harrison Gross, CEO of Innovative Eyewear, said "We are pleased to have entered into a license agreement with IngenioSpec. This multi-year. non-exclusive license includes patents directed to a wide variety of smart eyewear features which we may include in our future products. We believe the combination of this IP with Innovative Eyewear's current portfolio of 63 owned and exclusively licensed patents and applications, provides a potential competitive advantage for us in the smart eyewear marketplace."
Market didn't like the news. 🙄
https://www.rttnews.com/3415014/innovative-eyewear-announces-license-agreement-and-patent-settlement-with-ingeniospec.aspx
Well Porky,
Credit to you for forecasting Valirx accurately, I humbly take back my critique of your obsession with the "cash runway".
I'm fully anticipating a mid afternoon RNS with all resolutions passed, along with a fatuous statement from Cox about a "transformational 2024".
What's your prediction for the next cash call? November 2024?
This statement was issued following the last fundraise;
"ValiRx Chairman, Kevin Cox commented: "We would like to thank shareholders for showing their support of our strategy to develop the tCRO through the approval of resolutions 1 to 3. We look forward to updating the market on progress in the near future."
All we've had is a grandiose RNS about an "invoice" - no facts or figures, partners, running costs or contract values.
Now they've come cap in hand wanting £400,000 for the "commercial and brand development" of Inaphaea!!
The arrogance of Dr Cox beggars belief.
Today the "full of confidence and unconcerned" pick up their wages and press ahead with yet another fund raise, despite having no meaningful progress to offer shareholders.
I've lost interest in webinars, Q&A's and updates - it's just propaganda.
Sadly, Porky was right. 🙄
Come on TRX, give me an exit strategy.
Calling £1 by end of next month - fast forward to 10:13.
https://youtu.be/ShgK5Q1rKNI
It's a stock chart analysis; take it, or leave it.
Bell up
Lucy up
Reebok deal online soon
Microsalt IPO
60,000lb salt order with a tier one food company.
Spread tightening, 7p to buy.
Hope springs eternal...🤣
Gross, Cohen and Dabrowski exercising stock options;
https://www.nasdaq.com/market-activity/stocks/lucy/sec-filings
Here you go Top;
http://tinyurl.com/ycyx5f93
As I understand it: you have to be above 1 dollar, for a period of 30 days, to maintain your listing.